Literature DB >> 10450272

Evaluation of bipolar disorder in inpatients with prelingual deafness.

N A Shapira1, M P DelBello, T D Goldsmith, B M Rosenberger, P E Keck.   

Abstract

OBJECTIVE: This study retrospectively examined the occurrence of bipolar disorder in patients with prelingual deafness who were hospitalized for a psychiatric disorder.
METHOD: The hospital charts since 1983 of all psychiatrically admitted deaf patients were retrospectively evaluated for diagnoses by using DSM-IV criteria. Those with a best-estimate diagnosis of bipolar disorder were compared to those with other diagnoses.
RESULTS: There were 28 patients with prelingual deafness who had at least one psychiatric diagnosis from 1983 to 1998. Upon chart review, 11 (39.3%) were diagnosed with bipolar disorder. Patients with bipolar disorder and deafness had rates of inaccurate discharge diagnoses that were similar to those of other deaf patients (70.8% versus 56.7%).
CONCLUSIONS: Bipolar disorder may be more common in inpatients with prelingual deafness than has been previously described in the literature. Further research regarding the sources contributing to misdiagnosis of psychiatric disorders in this population is warranted.

Entities:  

Mesh:

Year:  1999        PMID: 10450272     DOI: 10.1176/ajp.156.8.1267

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  3 in total

1.  Deaf client with bipolar illness: a case report.

Authors:  Maneesh Gupta; Jenny Caddy
Journal:  Clin Pract Epidemiol Ment Health       Date:  2007-09-28

Review 2.  Hearing impairment and nightmares: a theoretical insight.

Authors:  Maria Francisca Rego; Ivone Duarte; Rui Nunes
Journal:  Springerplus       Date:  2015-12-18

3.  A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder.

Authors:  A E Baum; N Akula; M Cabanero; I Cardona; W Corona; B Klemens; T G Schulze; S Cichon; M Rietschel; M M Nöthen; A Georgi; J Schumacher; M Schwarz; R Abou Jamra; S Höfels; P Propping; J Satagopan; S D Detera-Wadleigh; J Hardy; F J McMahon
Journal:  Mol Psychiatry       Date:  2007-05-08       Impact factor: 15.992

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.